![]() ![]() ![]() Thirty-six studies including 3,309 patients with stage I NSCLC treated with SBRT/SABR produced a meta-estimate of 44% (95% CI, 38–50%), with significant heterogeneity (Q =423.55, P<0.0001 I 2=91.74%). Results: There were 16 studies totaling 1,984 patients with stage I NSCLC treated with wedge resection. ![]() Heterogeneity was tested using the Q statistic and the I 2 statistic. Funnel plots were used to assess publication bias. The combined percent survival was calculated using random effect models. Data were processed and analyzed in R (version 3.4.2) and a summary estimate that accounted for the sample size of each study was calculated. Methods: Original research articles published between 19 were identified through the National Library of Medicine and National Institutes of Health PubMed database and through the reference lists of reviewed articles. This meta-analysis compares the 5-year overall survival (OS) of wedge resection and SBRT in patients with stage I non-small cell lung cancer (NSCLC). Policy of Dealing with Allegations of Research Misconductīackground: The comparative effectiveness of stereotactic body radiation therapy (SBRT) and wedge resection in the treatment of early stage lung cancer is still under debate.Policy of Screening for Plagiarism Process. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |